Showing of 36 results
From GLP-1 to Triple Agonists: Transforming Cardiometabolic Care
Ian Neeland, MD, explains how incretin therapies are improving outcomes in cardiovascular, metabolic, and related conditions, while exploring mechanisms, muscle preservation, and strategies for long-term success.
Advancing Heart Failure Research Across Borders
Varun Sundaram, MD, PhD, discusses how his experiences shaped his groundbreaking work in global heart failure research, from uncovering international differences in patient care to leading studies on GLP-1 therapies and advanced heart failure.
Transforming Valve Therapy from Research to Real-World Application
Guilherme Attizzani, MD, shares his inspiring journey beginning as a research fellow in intravascular imaging and rising to become a national and international leader in structural heart disease interventions.
University Hospitals-led Study Highlights Potential Role for GLP-1RA in Secondary Prevention of AF
Innovations in Cardiovascular Medicine & Surgery | May 2025
University Hospitals Preventive Cardiologist Authors Primer on Muscle Effects of GLP-1s
Innovations in Cardiovascular Medicine & Surgery | December 2024
UH Interventional Cardiologist Publishes Important New Findings on Women’s Heart Health in the New England Journal of Medicine
Innovations in Cardiovascular Medicine & Surgery | June 2024